Publication | Open Access
Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease
11
Citations
14
References
2022
Year
Sars-cov-2 InfectionMedicineAntiviral Drug DevelopmentAntiviral TherapyVirologyAntiviral DrugViral Structural ProteinPharmacologyAntiviral CompoundMain Protease
| Year | Citations | |
|---|---|---|
Page 1
Page 1